Search Results
Bortezomib-based triplet regimens in MM patients undergoing transplantation
Bortezomib and dexamethasone after ASCT for high-risk MM
Combining bortezomib and lenalidomide-based regimens for frontline MM
Results of the Myeloma XI study, a quadruplet regimen for transplant eligible patients
Transplant vs bortezomib and LEN/DEX in multiple myeloma
What is the best treatment regimen for MM?
Triplet Regimens With Pomalidomide in Patients With Multiple Myeloma
OPTIMAL: bortezomib-based therapy vs thalidomide-based therapy in myeloma with renal failure
Isatuximab + Len/Dex/Bortezomib vs IsaRd in Newly Diagnosed Transplant Ineligible Multiple Myeloma
Future Directions for Novel and Next Generation Therapy in Multiple Myeloma | Dana-Farber
Real world data: bortezomib-based therapy for R/R myeloma
Best Treatment Options for Transplant Ineligible Myeloma Patients: Doublets-Triplets?
